Close Menu

NEW YORK (GenomeWeb) – Trovagene said today that it has signed new distribution agreements for its Trovera liquid biopsy tests with seven companies across Europe and the Middle East.

These new strategic partners include Alliance Global for the Middle East, Africa, and Central and South Asia; Instituto Diagnostico and Sorgente Genetica Varelli in Italy; Progenetics in Israel; Amplitech in France, Belgium, and Switzerland; NM Genomix for Bulgaria and Eastern Europe; and Diagnostica Longwood in Spain and Portugal.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.